134 related articles for article (PubMed ID: 16257501)
21. Examination of the in vitro degradation of [14C] pentaerythritol tetranitrate in rat and human blood with an improved thin-layer radiochromatographic procedure.
King SY; Fung HL
J Chromatogr; 1985 Sep; 343(1):129-37. PubMed ID: 4066847
[TBL] [Abstract][Full Text] [Related]
22. Quantification of drugs in plasma without primary reference standards by liquid chromatography-chemiluminescence nitrogen detection: application to tramadol metabolite ratios.
Ojanperä S; Rasanen I; Sistonen J; Pelander A; Vuori E; Ojanperä I
Ther Drug Monit; 2007 Aug; 29(4):423-8. PubMed ID: 17667796
[TBL] [Abstract][Full Text] [Related]
23. A validated stability indicating rapid LC method for duloxetine HCl.
Srinivasulu P; Srinivas KS; Reddy RS; Mukkanti K; Buchireddy R
Pharmazie; 2009 Jan; 64(1):10-3. PubMed ID: 19216224
[TBL] [Abstract][Full Text] [Related]
24. A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine.
Gilbert JD; Aylott RI; Draffan GH; Sögtrop HH
Arzneimittelforschung; 1982; 32(5):571-4. PubMed ID: 7201836
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics research on effect of doping defects on properties of PETN.
Qi CB; Wang T; Miao S; Wang YL; Hang GY
J Mol Model; 2019 Aug; 25(9):287. PubMed ID: 31471647
[TBL] [Abstract][Full Text] [Related]
26. Quality control in combinatorial chemistry: determinations of amounts and comparison of the "purity" of LC-MS-purified samples by NMR, LC-UV and CLND.
Letot E; Koch G; Falchetto R; Bovermann G; Oberer L; Roth HJ
J Comb Chem; 2005; 7(3):364-71. PubMed ID: 15877465
[TBL] [Abstract][Full Text] [Related]
27. Stability of ertapenem in aqueous solutions.
Zajac M; Cielecka-Piontek J; Jelińska A
J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
29. Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in rats.
Canal-Raffin M; Receveur M; Martinez B; Titier K; Ohayon C; Baldi I; Molimard M; Moore N; Brochard P
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):106-13. PubMed ID: 18343208
[TBL] [Abstract][Full Text] [Related]
30. Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.
Grimmsmann T; Chenot JF; Angelow A
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):803-11. PubMed ID: 26043680
[TBL] [Abstract][Full Text] [Related]
31. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection.
Grotto D; Santa Maria LD; Boeira S; Valentini J; Charão MF; Moro AM; Nascimento PC; Pomblum VJ; Garcia SC
J Pharm Biomed Anal; 2007 Jan; 43(2):619-24. PubMed ID: 16949242
[TBL] [Abstract][Full Text] [Related]
32. Effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate in experimental atherosclerosis.
Kojda G; Noack E
Agents Actions Suppl; 1995; 45():201-6. PubMed ID: 7717181
[TBL] [Abstract][Full Text] [Related]
33. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
Reinders MK; Nijdam LC; van Roon EN; Movig KL; Jansen TL; van de Laar MA; Brouwers JR
J Pharm Biomed Anal; 2007 Oct; 45(2):312-7. PubMed ID: 17890037
[TBL] [Abstract][Full Text] [Related]
34. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate.
Fink B; Bassenge E
J Cardiovasc Pharmacol; 1997 Dec; 30(6):831-6. PubMed ID: 9436825
[TBL] [Abstract][Full Text] [Related]
35. Stability of daphnoretin in vitro.
Zheng L; Yang WW; Guo JY; Jia YR; Sun LX
Pharmazie; 2012 Apr; 67(4):277-82. PubMed ID: 22570931
[TBL] [Abstract][Full Text] [Related]
36. Validation of a HPLC method for the quantification and purity determination of SK3530 in drug substance and tablet.
Oh JG; Jang WJ; Chi SC
J Pharm Biomed Anal; 2007 Feb; 43(3):1179-84. PubMed ID: 17134866
[TBL] [Abstract][Full Text] [Related]
37. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring.
Allanson AL; Cotton MM; Tettey JN; Boyter AC
J Pharm Biomed Anal; 2007 Aug; 44(4):963-9. PubMed ID: 17531423
[TBL] [Abstract][Full Text] [Related]
38. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
Hadad GM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
[TBL] [Abstract][Full Text] [Related]
39. Reproductive and developmental effects and physical and chemical properties of pentaerythritol tetranitrate (PETN) in the rat.
Quinn MJ; Crouse LC; McFarland CA; LaFiandra EM; Johnson MS
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):65-71. PubMed ID: 19197946
[TBL] [Abstract][Full Text] [Related]
40. Comparison of HPLC and CE methods for the determination of cetirizine dihydrochloride in human plasma samples.
Kowalski P; Plenis A
Biomed Chromatogr; 2007 Sep; 21(9):903-11. PubMed ID: 17443836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
